Cargando…

Utilizing national patient-register data to control for comorbidity in prognostic studies

OBJECTIVE: To construct an updated comorbidity index (Patient Register Index [PRI]) using national data collections from Norway and compare its predictive ability of 1-year mortality with the Charlson Comorbidity Index (CCI). MATERIALS AND METHODS: Data regarding over 1.11 million patients registere...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilssen, Yngvar, Strand, Trond-Eirik, Wiik, Robert, Bakken, Inger Johanne, Yu, Xue Qin, O’Connell, Dianne L, Møller, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216019/
https://www.ncbi.nlm.nih.gov/pubmed/25368532
http://dx.doi.org/10.2147/CLEP.S70742
_version_ 1782342194683707392
author Nilssen, Yngvar
Strand, Trond-Eirik
Wiik, Robert
Bakken, Inger Johanne
Yu, Xue Qin
O’Connell, Dianne L
Møller, Bjørn
author_facet Nilssen, Yngvar
Strand, Trond-Eirik
Wiik, Robert
Bakken, Inger Johanne
Yu, Xue Qin
O’Connell, Dianne L
Møller, Bjørn
author_sort Nilssen, Yngvar
collection PubMed
description OBJECTIVE: To construct an updated comorbidity index (Patient Register Index [PRI]) using national data collections from Norway and compare its predictive ability of 1-year mortality with the Charlson Comorbidity Index (CCI). MATERIALS AND METHODS: Data regarding over 1.11 million patients registered in the Norwegian Patient Register in 2010 and 2011 were used to construct the PRI. The PRI was evaluated by comparing its model fit and discrimination with the CCI. RESULTS: Compared with the CCI, the PRI weights decreased for six, increased for four, and were unchanged for seven diseases. When the PRI was added to the model including age and sex, the age effects were reduced by up to 38% for patients older than 50 years. All measures of model fit improved for the PRI model. CONCLUSION: Adjustment for comorbidity is especially important for patients 50 years of age or older, and its effect on 1-year mortality is almost comparable to the age effect. The PRI is based on more recent data than the CCI, and is more representative of the general population due to its construction.
format Online
Article
Text
id pubmed-4216019
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42160192014-11-03 Utilizing national patient-register data to control for comorbidity in prognostic studies Nilssen, Yngvar Strand, Trond-Eirik Wiik, Robert Bakken, Inger Johanne Yu, Xue Qin O’Connell, Dianne L Møller, Bjørn Clin Epidemiol Original Research OBJECTIVE: To construct an updated comorbidity index (Patient Register Index [PRI]) using national data collections from Norway and compare its predictive ability of 1-year mortality with the Charlson Comorbidity Index (CCI). MATERIALS AND METHODS: Data regarding over 1.11 million patients registered in the Norwegian Patient Register in 2010 and 2011 were used to construct the PRI. The PRI was evaluated by comparing its model fit and discrimination with the CCI. RESULTS: Compared with the CCI, the PRI weights decreased for six, increased for four, and were unchanged for seven diseases. When the PRI was added to the model including age and sex, the age effects were reduced by up to 38% for patients older than 50 years. All measures of model fit improved for the PRI model. CONCLUSION: Adjustment for comorbidity is especially important for patients 50 years of age or older, and its effect on 1-year mortality is almost comparable to the age effect. The PRI is based on more recent data than the CCI, and is more representative of the general population due to its construction. Dove Medical Press 2014-10-24 /pmc/articles/PMC4216019/ /pubmed/25368532 http://dx.doi.org/10.2147/CLEP.S70742 Text en © 2014 Nilssen et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Nilssen, Yngvar
Strand, Trond-Eirik
Wiik, Robert
Bakken, Inger Johanne
Yu, Xue Qin
O’Connell, Dianne L
Møller, Bjørn
Utilizing national patient-register data to control for comorbidity in prognostic studies
title Utilizing national patient-register data to control for comorbidity in prognostic studies
title_full Utilizing national patient-register data to control for comorbidity in prognostic studies
title_fullStr Utilizing national patient-register data to control for comorbidity in prognostic studies
title_full_unstemmed Utilizing national patient-register data to control for comorbidity in prognostic studies
title_short Utilizing national patient-register data to control for comorbidity in prognostic studies
title_sort utilizing national patient-register data to control for comorbidity in prognostic studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216019/
https://www.ncbi.nlm.nih.gov/pubmed/25368532
http://dx.doi.org/10.2147/CLEP.S70742
work_keys_str_mv AT nilssenyngvar utilizingnationalpatientregisterdatatocontrolforcomorbidityinprognosticstudies
AT strandtrondeirik utilizingnationalpatientregisterdatatocontrolforcomorbidityinprognosticstudies
AT wiikrobert utilizingnationalpatientregisterdatatocontrolforcomorbidityinprognosticstudies
AT bakkeningerjohanne utilizingnationalpatientregisterdatatocontrolforcomorbidityinprognosticstudies
AT yuxueqin utilizingnationalpatientregisterdatatocontrolforcomorbidityinprognosticstudies
AT oconnelldiannel utilizingnationalpatientregisterdatatocontrolforcomorbidityinprognosticstudies
AT møllerbjørn utilizingnationalpatientregisterdatatocontrolforcomorbidityinprognosticstudies